Des-Acetyl-Cetrorelix lacks the N-terminal acetyl group found in cetrorelix, increasing overall basicity and altering terminal hydrogen bonding. Researchers compare its folding, solubility, and receptor-binding characteristics with the parent compound. The variant helps elucidate the role of N-terminal capping in peptide performance. Applications include SAR analysis, peptide-stability studies, and analog-design refinement.
CAT No: Z10-101-208
CAS No:121081-09-2
Synonyms/Alias:THAT; 3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-D-citrullyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide; Des-Acetyl Cetrorelix; D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More